SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is seeing significant market activity and heightened community discourse driven by persistent acquisition rumors and notable institutional volume in after-hours trading. Traders are actively debating the stock's valuation relative to its rare disease pipeline, while observing unconventional trading patterns that have fueled speculation of a potential buyout.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

The Grayscale Bitcoin Mini Trust ETF is trending as investors grapple with heightened market volatility driven by escalating geopolitical tensions and institutional debates over Bitcoin's long-term utility as a hedge. The community remains deeply divided, with bulls pointing to historical price cycles and potential regulatory breakthroughs like the Clarity Act, while bears are emphasizing downside risks linked to broader economic uncertainty and shifting institutional flow dynamics.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

Norwegian Cruise Line is under intense pressure as a confluence of weak revenue guidance, rising fuel costs driven by geopolitical instability, and activist-led governance concerns weigh on the stock. While community members are actively debating the potential for a strategic turnaround or buyout, many investors remain wary of ongoing macro headwinds and sector-wide weakness.

Secret is the native coin of the Secret Network, a decentralized network for private / secure computation. Nodes on the network (known as secret nodes) can perform generalizable computations over encrypted data, which allows smart contracts (known as secret contracts) to use private and sensitive data as inputs. Our focus is on computational privacy, not just transactional privacy. Developers can build decentralized, privacy-preserving "Secret Apps" on the network. The privacy functionality of the Secret Network is critical for many fields, including decentralized finance, Web3, machine learning, access control, and many more.  The Secret Network is supported by many independent development teams and entities, including Enigma, Secret Foundation, Secretnodes.org, Chain of Secrets, and more

Secret 

Secret (SCRT) is experiencing a surge in community interest driven by the rapid expansion of its confidential computing ecosystem and integration with AI-powered validators. Investors are actively discussing the potential of its privacy-preserving smart contracts and liquidity farming initiatives, frequently highlighting the project's role alongside other privacy-focused assets within the broader crypto market.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals (REGN) is currently seeing heightened trading activity as investors react to regulatory challenges at a third-party manufacturing facility, which has triggered delays for key products like Eylea HD. While sentiment remains divided due to these supply chain hurdles and competitive pressure in the ophthalmology space, the community is closely monitoring upcoming earnings and pipeline developments, with many bulls pointing to strong revenue growth from blockbusters like Dupixent and Libtayo as reasons for long-term optimism.

Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include Core, Cognitive Adjacencies, and Network Software and Services. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA.

Arista Networks Inc

Arista Networks is currently trending due to intense volatility following a quarterly earnings report that featured a strong double beat on top and bottom lines but provided cautious forward revenue guidance. The community is actively debating whether the double-digit price decline is a baseless overreaction caused by market makers or a justified correction given the stock's high valuation and competitive concerns within the AI infrastructure sector.

ARK ETF Trust - ARK Innovation ETF

ARK Innovation ETF

The ARK Innovation ETF is seeing heightened volatility as community sentiment remains deeply divided over Cathie Wood's aggressive trading strategies, with critics pointing to its long-term underperformance while others track her frequent shifts in positions among speculative tech and crypto-linked holdings. Discussions center on the fund's role as a high-beta barometer for market risk, with traders actively debating its recent technical breakdowns, rotational selling, and the impact of her latest rebalancing moves on sentiment for growth-focused assets.

Ciena Corp. is a network technology company, which engages in the provision of hardware, software, and services to network operators, as well as enabling enhanced network capacity, service delivery, and automation. It operates through the following segments: Networking Platforms, Platform Software and Services, Blue Planet Automation Software and Services, and Global Services. The Networking Platforms segment consists of converged packet optical and packet networking portfolios. The Platform Software and Services segment provides analytics, data, and planning tools to assist customers in managing its networking platforms products. The Blue Planet Automation Software and Services segment enables customers to implement large-scale software and IT-led OSS transformations by transforming legacy networks into service ready networks. The Global Services segment offers a broad suite of value-added services. The company was founded by Patrick H. Nettles and Kevin Brian Kimberlin in 1992 and is headquartered in Hanover, MD.

CIENA Corp.

Ciena Corp is drawing investor attention as it solidifies its role in the critical AI infrastructure and photonics supply chain, with the community closely tracking recent gains and the potential for the optics sector to emerge as a key market leader. Traders are actively debating whether to capitalize on this upward momentum or manage risk amid broader sector volatility and technical test points.

Coherent Corp. engages in the development, refinement, manufacturing, and marketing of engineered materials, opto-electronic components and devices, and lasers for use in the industrial, communications, electronics, and instrumentation markets. It operates through the following segments: Networking, Materials, and Lasers. The Networking segment leverages compound semiconductor technology platforms and deep knowledge of end-user applications. The Materials segment markets engineered materials and optoelectronic devices. The Lasers segment serves industrial customers in semiconductor capital equipment, display capital equipment, precision manufacturing, and aerospace and defense, as well as instrumentation customers in life sciences and scientific research. The company was founded by Carl J. Johnson in 1971 and is headquartered in Saxonburg, PA.

Coherent Corp

Coherent Corp is trending as investors aggressively position in the AI infrastructure supply chain, specifically betting on the necessity of high-speed photonics and optical interconnects. Community sentiment remains focused on the company's role as a mission-critical supplier for hyperscalers, with active discussions weighing the stock's recent price volatility against its strategic importance in overcoming bandwidth bottlenecks.

Nu Holdings Ltd. is a holding company, which engages in the provision of digital banking services. The company was founded by David Vélez Osorno, Cristina Helena Zingaretti Junqueira, and Adam Edward Wible on February 26, 2016 and is headquartered in George Town, Cayman Islands.

Nu Holdings Ltd - Ordinary Shares Class A

Nu Holdings Ltd

Nu Holdings is facing significant volatility and investor frustration as the stock struggles to sustain upward momentum, leading to heavy discussion around its repetitive price suppression and perceived institutional manipulation. While bulls remain focused on the company's long-term fintech growth, global expansion efforts, and potential U.S. banking license as core catalysts, bears and weary retail traders are voicing deep disappointment over stagnant price action and recent technical weakness.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Park National (PRK) Upgraded to Strong Buy: Here's What You Should Know

Park National (PRK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Park National (PRK) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for Park National (PRK) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Park National (PRK) Q4 Earnings and Revenues Surpass Estimates

Park National (PRK) delivered earnings and revenue surprises of +5.90% and +2.26%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Park National (PRK) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Park National (PRK) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Park National (PRK) Beats Q3 Earnings and Revenue Estimates

Park National (PRK) delivered earnings and revenue surprises of +5.13% and +1.07%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Old Second Bancorp (OSBC) Q3 Earnings and Revenues Top Estimates

Old Second Bancorp (OSBC) delivered earnings and revenue surprises of +3.92% and +4.56%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Park National (PRK) Q2 Earnings and Revenues Beat Estimates

Park National (PRK) delivered earnings and revenue surprises of +17.41% and +5.40%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Civista Bancshares (CIVB) Q2 Earnings and Revenues Lag Estimates

Civista Bancshares (CIVB) delivered earnings and revenue surprises of -4.35% and -2.37%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Park National Corp. is a holding company, which engages in the provision of banking and non-banking financial services through its subsidiaries. The company was founded in 1986 and is headquartered in Newark, OH.

Park National Corp.

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	$2.67	--	--	N/A
Q4 '25	$2.80	$2.93	4.64%	BEAT
Q3 '25	$2.73	$2.87	4.94%	BEAT
Q2 '25	$2.45	$2.90	18.49%	BEAT
Q1 '25	$2.15	$2.57	19.35%	BEAT

PRK
Park National Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest PRK News

PRKPark National Corp.